Website
http://dataportal.arc.gov.au/NCGP/API/grants/LP0349255
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Validating protozoa-specific drug targets using peptides from biodiverse gene fragment libraries. Cryptosporidium and the trypanosomes are protozoan parasites, which have a global impact on the health, survival and economic development of millions of people and animals world wide. New therapies for the diseases they cause are urgently required. We describe a novel means of identifying protozoa-specific peptides that will inhibit the formation of essential protein complexes, which have no effect on the mammalian host. Candidate peptides will then be used to validate these protein complexes as new targets for the development of peptide-based therapeutic compounds. This project will validate novel targets for the development of new treatments for these diseases.Funded Activity Details
Start Date: 12-2003
End Date: 12-2008
Funding Scheme: Linkage Projects
Funding Amount: $310,000.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Genetic Technologies: Transformation, Site-Directed Mutagenesis, Etc. | Microbiology | Infectious Agents
ANZSRC Socio-Economic Objective (SEO)
Infectious diseases | Treatments (e.g. chemicals, antibiotics) | Treatments (e.g. chemicals, antibiotics) |
